TrialClinical pharmacokinetics2025

A Phase IIa, Single-Blind, Placebo-Controlled, Parallel-Group Study to Assess Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Brensocatib in Adults with Cystic Fibrosis.

Michael W Konstan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.